JP2020529472A5 - - Google Patents

Download PDF

Info

Publication number
JP2020529472A5
JP2020529472A5 JP2020527859A JP2020527859A JP2020529472A5 JP 2020529472 A5 JP2020529472 A5 JP 2020529472A5 JP 2020527859 A JP2020527859 A JP 2020527859A JP 2020527859 A JP2020527859 A JP 2020527859A JP 2020529472 A5 JP2020529472 A5 JP 2020529472A5
Authority
JP
Japan
Prior art keywords
group
formula
compound
alkyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020527859A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020529472A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/044182 external-priority patent/WO2019023634A1/en
Publication of JP2020529472A publication Critical patent/JP2020529472A/ja
Publication of JP2020529472A5 publication Critical patent/JP2020529472A5/ja
Pending legal-status Critical Current

Links

JP2020527859A 2017-07-28 2018-07-27 ペプチド化合物の環化放出関連する出願の相互参照 Pending JP2020529472A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762538477P 2017-07-28 2017-07-28
US62/538,477 2017-07-28
PCT/US2018/044182 WO2019023634A1 (en) 2017-07-28 2018-07-27 CYCLATIVE RELEASE OF PEPTIDE COMPOUNDS

Publications (2)

Publication Number Publication Date
JP2020529472A JP2020529472A (ja) 2020-10-08
JP2020529472A5 true JP2020529472A5 (https=) 2021-09-09

Family

ID=63312461

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020527859A Pending JP2020529472A (ja) 2017-07-28 2018-07-27 ペプチド化合物の環化放出関連する出願の相互参照

Country Status (4)

Country Link
US (1) US11299513B2 (https=)
EP (1) EP3658567A1 (https=)
JP (1) JP2020529472A (https=)
WO (1) WO2019023634A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112592382B (zh) * 2020-11-27 2022-10-04 安徽大学 一种树脂及其制备方法以及其在制备头尾环肽中的应用
CN121248729A (zh) * 2025-06-12 2026-01-02 杭州湃肽生化科技有限公司 一种全保护环肽及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP616598A0 (en) * 1998-09-25 1998-10-15 University Of Queensland, The Auxiliary for amide bond formation
GB2369823B (en) 1999-11-30 2003-06-04 Cyclacel Ltd Assays for cyclin-interacting compounds
GB9928323D0 (en) 1999-11-30 2000-01-26 Cyclacel Ltd Peptides
US20050153894A1 (en) 1999-11-30 2005-07-14 Cyclacel Limited p21 peptides
US20040053849A1 (en) 2000-12-20 2004-03-18 Bair Kenneth Walter Inhibitors of the E2F-1/cyclin interaction for cancer therapy
BR0116330A (pt) 2000-12-20 2004-02-25 Novartis Ag Inibidores da interação e2f-1/ciclina para terapia de câncer
US20040077549A1 (en) 2000-12-20 2004-04-22 Bair Kenneth Walter Inhibitors of the E2F-1/cyclin interaction for cancer therapy
JP2004269357A (ja) 2002-01-25 2004-09-30 Marine Biotechnol Inst Co Ltd 鉄と高い結合能を有する化合物およびその製造方法
WO2006105386A1 (en) 2005-03-30 2006-10-05 Genentech, Inc. Cdk2 inhibitors
WO2008000870A1 (es) 2006-06-19 2008-01-03 Fundación De La Comunidad Valenciana, Centro De Investigación Principe Felipe Compuestos orgánicos que inhiben la actividad catalítica del complejo ciclina a/kinasa 2 dependiente de ciclina mediante su unión a un nuevo sitio farmacofórico en la molécula de ciclina
US20110039763A1 (en) 2009-01-06 2011-02-17 C3 Jian, Inc. Targeted antimicrobial moieties
US9376465B2 (en) 2012-03-27 2016-06-28 University Of South Carolina Cyclin based inhibitors of CDK2 and CDK4
US20140296484A1 (en) 2013-03-27 2014-10-02 University Of South Carolina Cyclin Based Inhibitors of CDK2 and CDK4
US10011635B2 (en) 2013-09-27 2018-07-03 H. Lee Moffitt Cancer Center And Research Institute, Inc. Cyclic peptide conjugates and methods of use
WO2017046226A2 (en) 2015-09-17 2017-03-23 Histide Ag Pharmaceutical association for converting a neoplastic cell into a non-neoplastic cell and uses thereof.
CN109715195A (zh) 2015-09-17 2019-05-03 伊斯迪德股份公司 用于将赘生性细胞转化为非赘生性细胞的药物结合物及其用途
JP6890836B2 (ja) 2015-09-17 2021-06-18 ヒスタイド アクツィエンゲゼルシャフト 腫瘍細胞を非腫瘍細胞に変換するための医薬的連合体及びその使用
WO2017046229A1 (en) 2015-09-17 2017-03-23 Histide Ag Pharmaceutical association of growth factor receptor agonist and adhesion protein inhibitor for converting a neoplastic cell into a non-neoplastic cell and uses thereof
US20190330290A1 (en) 2015-09-17 2019-10-31 Histide Ag Pharmaceutical association of growth factor receptor agonist and adhesion protein inhibitor for converting a neoplastic cell into a non-neoplastic cell and uses thereof
KR20180050744A (ko) 2015-09-17 2018-05-23 히스티드 아게 신생물성 세포를 비-신생물성 세포로 전환시키기 위한 약제학적 회합물 및 이것의 용도

Similar Documents

Publication Publication Date Title
JP7139511B2 (ja) ペプチド化合物の製造方法、保護基形成用試薬、及び、縮合多環芳香族炭化水素化合物
ES2830974T3 (es) Nuevo agente protector de xanteno
JP6350632B2 (ja) ペプチドの製造方法
JP6092513B2 (ja) フルオレン化合物
JPH0670056B2 (ja) 新規テトラオキソ−ジアザビシクロ−（３，３，１）−ノナンおよびその製法
JP7238123B2 (ja) ペプチド化合物の製造方法、保護基形成用試薬、及び、縮合多環芳香族炭化水素化合物
JP3866279B2 (ja) ペプチド連結用の新規な試薬
JP2020529472A5 (https=)
JP6744293B2 (ja) オキシトシン類似体の製造方法
WO2019069978A1 (ja) ペプチド化合物の製造方法
JP2021505542A5 (https=)
JP2011251936A (ja) ウレイドシラン化合物
Nair et al. Formation of a pseudo-β-hairpin motif utilizing the Ant–Pro reverse turn: consequences of stereochemical reordering
ES2586408T3 (es) Preparación de intermedios de micafungina
JP4079314B2 (ja) シルセスキオキサン化合物の製造方法
TW202233574A (zh) 肽之製造方法、保護基形成用試藥及縮合多環化合物
KR20010079497A (ko) 혈관형성 억제제
JPWO2018088527A1 (ja) 新規トリチル保護剤
JP2020529472A (ja) ペプチド化合物の環化放出関連する出願の相互参照
CN120476131A (zh) 涉及位阻三叔丁基色氨酸（Tbt）残基的肽合成方法
US6265590B1 (en) Nα-2-(4-nitrophenylsulfonyl)ethoxycarbonyl-amino acids
JP5014148B2 (ja) ペプチドチオエステルの製造方法
JP6440250B2 (ja) チオアミド誘導体
JP6720913B2 (ja) 不飽和結合含有ビスシリル化合物およびその製造方法
JP2002531541A (ja) カルバメート結合を含むテンプレートとして作用する分子足場